Prevalence of Psoriatic Arthritis in a Large Cohort of Brazilian Patients with Psoriasis

Ranza, Roberto; Carneiro, Sueli Coelho da Silva; Qureshi, Abrar A.; Martins, Gisele; Rodrigues, Jorge; Romiti, Ricardo; Barros, Thiago Bitar Martins; Carneiro, Jamille Nascimento; Sampaio, Ana Luisa; Grynszpan, Rachel; Markus, Juliana; Pinto, Rogério Melo Costa; Goldenstein-Schainberg, Cláudia

doi:10.3899/jrheum.140474

Cited by 44 publications

(40 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This is consistent with the results reported in Ranza et al . (49.0%) that highlighted the frequency of undiagnosed cases. Some authors feel that the diagnosis of PsA should be facilitated by dermatologists, as underdiagnosis may lead to potentially avoidable joint damage that permanently disables and deforms some individuals …”

Section: Discussionmentioning

confidence: 95%

“…This study demonstrated that the prevalence of PsA findings among Brazilian patients with PsO is in agreement with other investigations performed in Brazilian cohorts. Carneiro et al . and Ranza et al .…”

Section: Discussionmentioning

confidence: 99%

“…Carneiro et al . and Ranza et al . reported PsA prevalence of 35.0% and 33.3%, respectively, using CASPAR.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Metabolic syndrome and psoriatic arthritis among patients with psoriasis vulgaris: Quality of life and prevalence

Souza

Castro

Carneiro

et al. 2018

The Journal of Dermatology

Self Cite

View full text Add to dashboard Cite

Interest has increased in comorbidities associated with psoriasis and their effects on health‐related quality of life (HRQoL). This study aimed to evaluate the prevalence of metabolic syndrome (MetS) and psoriatic arthritis (PsA) and to investigate HRQoL and the prevalence of hypertension, type 2 diabetes mellitus (T2DM), obesity and dyslipidemia. In a cross‐sectional design, patients diagnosed with plaque psoriasis answered an interview and standardized questionnaires (Dermatology Life Quality Index questionnaire [ DLQI ], 36‐Item Short Form Health Survey [SF‐36] and EuroQol Five‐Dimension Questionnaire Three‐Level version [ EQ ‐5D‐3L]). Physical examination and several tests to assess desired outcomes were performed by a dermatologist and a rheumatologist during three visits. The prevalence of MetS and PsA was 50.0% and 41.8%, respectively. Dyslipidemia was the most prevalent (74.5%) secondary comorbidity, followed by hypertension (61.8%), obesity (52.5%) and T2DM (30.9%). The mean (standard deviation) DLQI score was 6.5 (6.9), and mean physical and mental SF‐36 measures were 45.2 (10.4) and 45.5 (12.3), respectively, and for EQ‐5D‐3L, mean utility index and EQ ‐ VAS scores were 0.68 (0.27) and 72.7 (19.7), respectively. PsA and MetS are important comorbidities; a reduced HRQoL is noted among plaque psoriasis patients with these comorbidities, emphasizing the relevance of diagnosis and treatment beyond the care of skin lesions.

show abstract

Section: Discussionmentioning

confidence: 95%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Metabolic syndrome and psoriatic arthritis among patients with psoriasis vulgaris: Quality of life and prevalence

Souza

Castro

Carneiro

et al. 2018

The Journal of Dermatology

Self Cite

View full text Add to dashboard Cite

show abstract

“…It is likely that many of the cases are first‐degree relatives, some of whom may be self‐reported. Patients with familial history of PsA developed psoriasis as well as inflammatory arthritis at an earlier age …”

Section: Discussionmentioning

confidence: 99%

Epidemiological analysis of psoriatic arthritis patients in Japan

Yamamoto

Ohtsuki

Sano

et al. 2016

The Journal of Dermatology

View full text Add to dashboard Cite

To determine the current status of psoriatic arthritis, we conducted a retrospective survey by sending questionnaires. The newly visited psoriatic arthritis patients accounted for 10.5% (95% confidence interval, 7.9-13%) of all newly visited psoriasis patients (n = 2581) between April 2014 and March 2015 in 73 institutes. Additionally, questionnaires on detailed patients' information were returned by 92 institutes (response rate, 70.8%), where 1282 patients with psoriatic arthritis were identified. There was a male predominance. The mean onset age of psoriatic arthritis was 44.9 years, and mean onset age for cutaneous psoriasis (36.4 years) was lower than that for arthritis (45.1 years). The mean duration in patients who developed psoriasis prior to arthritis was 11.2 years, while that in patients preceded by arthritis was 4.4 years. According to the Moll and Wright criteria, polyarthritis type was most common (36%), followed by distal interphalangeal type (26%) and oligoarthritis type (22%). Peripheral joint pain was 61.5%, back pain such as lumbago and neck pain was 34.3%. Enthesitis and dactylitis were observed in 28.3% and 59.2%, respectively. Biologics were used in 55.5% of psoriatic arthritis patients, and 31% used disease-modifying antirheumatic drugs. In conclusion, the ratio of psoriatic arthritis in Japan is increasing, and nearly 10% of new psoriasis patients had psoriatic arthritis. This study shows the current status of psoriatic arthritis in Japan, including several unexpected findings such as male predominance, longer duration between the onset of cutaneous psoriasis and arthritis, and dominance of polyarthritis.

show abstract

“…По данным американских и евро-пейских исследователей [20,21], на долю больных ПсА приходится около 30% всех больных ПС. В бра-зильской популяции [22] ПсА отмечен у 33% паци-ентов с ПС. В азиатской популяции [23] распростра-ненность ПсА среди лиц с ПС значительно ниже -от 1 до 9%.…”

unclassified